19,858 reports of this reaction
5.6% of all LEVONORGESTREL reports
#2 most reported adverse reaction
DEVICE DISLOCATION is the #2 most commonly reported adverse reaction for LEVONORGESTREL, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 19,858 FDA adverse event reports linking LEVONORGESTREL to DEVICE DISLOCATION. This represents approximately 5.6% of all 357,584 adverse event reports for this drug.
Patients taking LEVONORGESTREL who experience device dislocation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE DISLOCATION is moderately reported among LEVONORGESTREL users, representing a notable but not dominant share of adverse events.
In addition to device dislocation, the following adverse reactions have been reported for LEVONORGESTREL:
The following drugs have also been linked to device dislocation in FDA adverse event reports:
DEVICE DISLOCATION has been reported as an adverse event in 19,858 FDA reports for LEVONORGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE DISLOCATION accounts for approximately 5.6% of all adverse event reports for LEVONORGESTREL, making it one of the most commonly reported side effect.
If you experience device dislocation while taking LEVONORGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.